Revises requirements for health insurers to cover telemedicine and telehealth; requires telemedicine and telehealth systems to include accessible communication features for individuals with disabilities.
Impact
The legislation prohibits insurance carriers from imposing 'place of service' restrictions, allowing healthcare providers to deliver services through telemedicine and telehealth regardless of their physical location, as long as they are licensed to practice in New Jersey. This represents a substantial expansion of access to care, particularly useful for individuals with barriers to in-person access, including those with disabilities. Additionally, the requirements include that telehealth systems must incorporate accessible communication features to accommodate users with various disabilities, reflecting a commitment to inclusivity.
Summary
Senate Bill S846, introduced on January 18, 2022, revises the existing telemedicine and telehealth law in New Jersey, specifically the provisions set forth in P.L.2017, c.117. The bill mandates that health benefits programs, including Medicaid and the New Jersey FamilyCare program, must provide comprehensive coverage for telemedicine and telehealth services. It ensures that reimbursement rates for these services are equal to those for equivalent in-person services, addressing a significant concern regarding equitable access to care regardless of the delivery method.
Conclusion
Overall, S846 represents a significant step toward enhancing the delivery of healthcare services in New Jersey through telemedicine and telehealth, promoting more equitable access to necessary care. By ensuring that reimbursement is equivalent to in-person services and emphasizing accessibility for individuals with disabilities, this bill acknowledges the changing paradigms of healthcare delivery while also addressing critical concerns surrounding equity and accessibility.
Contention
One notable point of contention in the discussions surrounding S846 relates to how health benefits plans and providers will deal with the regulatory landscape of telemedicine. Questions have been raised regarding the enforcement of compliance with existing health privacy rules and quality care standards. The bill aims to prevent any healthcare provider from facing disciplinary action solely based on their engagement in telemedicine, which could lead to concerns regarding the quality and accountability of care delivered remotely. These regulatory aspects will be crucial as the healthcare landscape continues to evolve in response to increased reliance on technology.
Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.
Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.